Imagen del laboratorio de microbiología de Sandoz, la segunda farmacéutica que más ensayos llevó a cabo en Alemania Oriental. / Flickr – Novartis “Un grupo de investigadores de centros alemanes indagó en los ensayos clínicos realizados en la República Democrática Alemana (RDA) por parte de las compañías farmacéuticas occidentales durante la Guerra Fría, desde 1983…
Month: October 2014
Response to my letter: “Any reason to not retract the two RE-LY papers published by The Lancet?”
Ramirez, Jorge H (2014): Requested (Jul 29, 2014) & Retracted by the author (Aug 23, 2014): “Conelly S, et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2009; 361:1139-1151”] – Question Thread Open. figshare. http://dx.doi.org/10.6084/m9.figshare.1144305
Quantum Strangeness & Becoming Oneself
“Our classical world is composed of mutually exclusive alternatives: Everything is either something or something else; it is a this or a that, though we may be unaware of these identities due to ignorance. A color is always either red or not red; two socks in a closed box are either a pair or not…
Scientific output (1975-2013): chaos theory vs. evidence based medicine
This question remains unanswered: Could you support with data that hierarchical levels of evidence based medicine are correct? (1) PubMed search terms for chaos theory and evidence based medicine available in reference 2. References Ramirez JH. Hypothesis: hierarchical levels of evidence based medicine are wrong. BMJ 2014 (letter). http://www.bmj.com/content/348/bmj.g3725/rr/762595 Ramirez, Jorge H (2014): Scientific output (1975-2013): chaos theory…
First price in BMA book awards: ‘Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare’ – Author: Peter Gøtzsche
A well deserved recognition for Peter Gøtzsche latest book. Read this story via the Council for Evidence-Based Psychiatry (CEP) website — Peter Gøtzsche’s latest book ‘Deadly Medicines and Organised Crime: How Big Pharma has Corrupted Healthcare’ wins first prize in BMA book awards 2014 — I will also translate this post to Spanish (in a different post after publish this…
John Ioannidis new article (published today – PLoS Medicine) + Interview (PLoS Blogs)
— From One to One Million Article Views: Q&A with Author John Ioannidis “From One to One Million Article Views: Q&A with Author John Ioannidis “PLOS’s Erica Kritsberg interviews John Ioannidis about the success of his article “Why Most Published Research Findings Are False”, which reached one million views in April this year.” John Ioannidis…
Apuntes de Editor – Compartido desde el nuevo blog de Mauricio Palacios.
Comparto desde el nuevo blog de Mauricio Palacios. Mauricio fue mi profesor de farmacología desde el postgrado en la Universidad del Valle, hoy mi colega y amigo en la misma institución y ojalá – en el futuro cercano – nuestro próximo decano de la Facultad de Salud en Univalle. Saludos Mauro, felicitaciones por tu blog y éxitos en el andar…
Re: Concerns over data in key dabigatran trial
Response to: Cohen Deborah. Concerns over data in key dabigatran trial. BMJ 2014;349:g4747 URL: http://www.bmj.com/content/349/bmj.g4747/rr/778288 October 17, 2014. Dear Editor, Concerns expressed by the BMJ investigation about the safety and efficacy of dabigatran in patients with atrial fibrillation are legitimate and well-founded.(1) Boehringer Ingelheim (BI) posted a response the same day these articles were published (July…
“Drug reps shift focus away from Doctors onto Administrators to Get on ‘Formulary’ -WSJ” – Reblogged @Pharmagossip
“So when the GlaxoSmithKline GSK.LN +0.73% PLC saleswoman began plugging two new lung-disease drugs to a big San Diego hospital system this spring, it was to an administrator who doesn’t see patients but helps write the menu, also called a “formulary,” of approved medications. Ms. French urged the administrator in the system, Sharp HealthCare, to…
Chaos Theory and Pharmacology 